Climate Impact and Advocacy: An Interview wit...

A man in his late 60s enters a lung cancer screening program and is found to have a 4.5 cm tumor—stage II by size, with high-stakes decisions ahead. The case seems to point toward modern perioperative therapy, until biomarker testing changes everything. In this episode, host Lisa ...  Show more

A woman in her early 60s, who never smoked in her lifetime, is diagnosed with stage II lung cancer after an abnormal chest X-ray—and believes surgery has ended the story. But postoperative pathology and molecular testing open a new chapter of therapy designed to lower recurrence ...  Show more

CHEST March 2025, Volume 167, Issue 3 CHEST journal's Editor in Chief, Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST March 2025 issue, including an exploration of the effectiveness of guideline-recommended activities for children with asthma ...  Show more

CHEST October 2024, Volume 166, Issue 4 CHEST® journal's Editor in Chief, Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST October 2024 issue, including research into characteristics of adults with severe asthma in childhood, the association of ...  Show more

Ophthalmology Editor-in-Chief, Russell Van Gelder, MD, PhD, and our new Associate Editor, Laura Downie, BOptom, PhD, guest host this special episode introducing "Ophthalmology Reviews." <span style= "mso-spacerun: yes;"> </span>Ophthalmology Reviews ...

For a probing discussion detailing the American Lung Association’s recent 2024 “State of Lung Cancer” report, we are joined by esteemed thoracic medical oncologist Dr. Jacob Sands of Dana-Farber Cancer Institute and Harvard Medical School. Offering insight into actionable targete ...  Show more